Critical roles for murine Reck in the regulation of vascular patterning and stabilization
暂无分享,去创建一个
Shuichiro Ogawa | Makoto Noda | M. Noda | T. Matsuzaki | Mako Yamamoto | Glícia Maria de Almeida | Yoko Morioka | Tomoko Matsuzaki | Y. Morioka | Mako Yamamoto | Shuichiro Ogawa
[1] Y. Yoshida,et al. Involvement of the SKP2–p27KIP1 pathway in suppression of cancer cell proliferation by RECK , 2012, Oncogene.
[2] Hui Wang,et al. MicroRNA-342 inhibits colorectal cancer cell proliferation and invasion by directly targeting DNA methyltransferase 1. , 2011, Carcinogenesis.
[3] M. Noda,et al. Density- and serum-dependent regulation of the Reck tumor suppressor in mouse embryo fibroblasts. , 2009, Cellular signalling.
[4] P. Zorzi,et al. The aortic ring model of angiogenesis. , 2008, Methods in enzymology.
[5] Salman Rahman,et al. Novel Vascular Endothelial Growth Factor Binding Domains of Fibronectin Enhance Vascular Endothelial Growth Factor Biological Activity , 2002, Circulation research.
[6] Napoleone Ferrara,et al. Developmental and pathological angiogenesis. , 2011, Annual review of cell and developmental biology.
[7] Y. Zhuang,et al. Increased miR‐222 in H. pylori‐associated gastric cancer correlated with tumor progression by promoting cancer cell proliferation and targeting RECK , 2012, FEBS letters.
[8] Y Ikawa,et al. Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[9] Johanna Andrae,et al. Role of platelet-derived growth factors in physiology and medicine. , 2008, Genes & development.
[10] H. Kitayama,et al. RECK Forms Cowbell-shaped Dimers and Inhibits Matrix Metalloproteinase-catalyzed Cleavage of Fibronectin* , 2009, Journal of Biological Chemistry.
[11] B. Vojnovic,et al. Use of the mouse aortic ring assay to study angiogenesis , 2011, Nature Protocols.
[12] L. Luo,et al. A global double‐fluorescent Cre reporter mouse , 2007, Genesis.
[13] M. Noda,et al. Recklessness as a hallmark of aggressive cancer , 2007, Cancer science.
[14] R. Hammer,et al. Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. , 2001, Developmental biology.
[15] H. Kitayama,et al. A novel screen using the Reck tumor suppressor gene promoter detects both conventional and metastasis-suppressing anticancer drugs , 2010, Oncotarget.
[16] Stanley J. Wiegand,et al. Vascular-specific growth factors and blood vessel formation , 2000, Nature.
[17] T. Wurdinger,et al. MicroRNA 21 Promotes Glioma Invasion by Targeting Matrix Metalloproteinase Regulators , 2008, Molecular and Cellular Biology.
[18] T. Ohtsuka,et al. RECK modulates Notch signaling during cortical neurogenesis by regulating ADAM10 activity , 2007, Nature Neuroscience.
[19] Andrew J. Ewald,et al. Matrix metalloproteinases and the regulation of tissue remodelling , 2007, Nature Reviews Molecular Cell Biology.
[20] H. Hiai,et al. E-cadherin–downregulation and RECK-upregulation are coupled in the non-malignant epithelial cell line MCF10A but not in multiple carcinoma-derived cell lines , 2014, Scientific Reports.
[21] H. Kiyonari,et al. Involvement of the Reck tumor suppressor protein in maternal and embryonic vascular remodeling in mice , 2010, BMC Developmental Biology.
[22] Lei Xu,et al. Normalization of the vasculature for treatment of cancer and other diseases. , 2011, Physiological reviews.
[23] R. Hammer,et al. Smooth muscle-selective deletion of guanylyl cyclase-A prevents the acute but not chronic effects of ANP on blood pressure , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[24] David B. Alexander,et al. The Membrane-Anchored MMP Inhibitor RECK Is a Key Regulator of Extracellular Matrix Integrity and Angiogenesis , 2001, Cell.
[25] H. Kitayama,et al. Hypoxia and RAS-signaling pathways converge on, and cooperatively downregulate, the RECK tumor-suppressor protein through microRNAs , 2010, Oncogene.
[26] H. Kitayama,et al. The membrane-anchored metalloproteinase regulator RECK stabilizes focal adhesions and anterior–posterior polarity in fibroblasts , 2009, Oncogene.
[27] K. Okawa,et al. The Reversion-inducing Cysteine-rich Protein with Kazal Motifs (RECK) Interacts with Membrane Type 1 Matrix Metalloproteinase and CD13/Aminopeptidase N and Modulates Their Endocytic Pathways* , 2007, Journal of Biological Chemistry.
[28] R. Nicosia,et al. Growth of microvessels in serum-free matrix culture of rat aorta. A quantitative assay of angiogenesis in vitro. , 1990, Laboratory investigation; a journal of technical methods and pathology.
[29] W. Kong,et al. Keratinization-associated miR-7 and miR-21 Regulate Tumor Suppressor Reversion-inducing Cysteine-rich Protein with Kazal Motifs (RECK) in Oral Cancer* , 2012, The Journal of Biological Chemistry.
[30] Amber N. Stratman,et al. Endothelial Cell-Pericyte Interactions Stimulate Basement Membrane Matrix Assembly: Influence on Vascular Tube Remodeling, Maturation, and Stabilization , 2011, Microscopy and Microanalysis.
[31] Z. Werb,et al. Matrix Metalloproteinases: Regulators of the Tumor Microenvironment , 2010, Cell.
[32] P. Carmeliet,et al. Molecular mechanisms and clinical applications of angiogenesis , 2011, Nature.
[33] I. Geudens,et al. Coordinating cell behaviour during blood vessel formation , 2011, Development.
[34] S. Itohara,et al. The transformation suppressor gene Reck is required for postaxial patterning in mouse forelimbs , 2012, Biology Open.
[35] R. Dahiya,et al. MicroRNA-182-5p Promotes Cell Invasion and Proliferation by Down Regulating FOXF2, RECK and MTSS1 Genes in Human Prostate Cancer , 2013, PloS one.
[36] C. Betsholtz. Insight into the physiological functions of PDGF through genetic studies in mice. , 2004, Cytokine & growth factor reviews.
[37] Chiaki Takahashi,et al. RECK: A novel suppressor of malignancy linking oncogenic signaling to extracellular matrix remodeling , 2003, Cancer and Metastasis Reviews.
[38] M. Noda,et al. Involvement of the Sp1 site in ras-mediated downregulation of the RECK metastasis suppressor gene. , 1999, Biochemical and biophysical research communications.
[39] H. Klüver,et al. A method for the combined staining of cells and fibers in the nervous system. , 1953, Journal of neuropathology and experimental neurology.
[40] Laure Gambardella,et al. A Computational Tool for Quantitative Analysis of Vascular Networks , 2011, PloS one.
[41] K. Rauen,et al. The RASopathies. , 2013, Annual review of genomics and human genetics.
[42] H. Dvorak. Discovery of vascular permeability factor (VPF). , 2006, Experimental cell research.
[43] K. Alitalo,et al. How do angiopoietins Tie in with vascular endothelial growth factors? , 2010, Current opinion in hematology.